C26-A6 works at μM concentrations in vitro, and a new compound C19 was generated which disrupted AEG-1/SND1 interaction at nM concentrations and also inhibited MCF-7 human breast cancer xenografts in nude mice [78]. The gene discussed is MTDH; the disease is breast carcinoma.